Galactosamine-Conjugating Zwitterionic Block Copolymer for Reduction-Responsive Release and Active Targeted Delivery of Doxorubicin to Hepatic Carcinoma Cells

Figure 7

Tumor volume changes of the Bcap37 tumor-bearing nude mice after treatment with PBS or DOX at an equivalent dose of 4 mg/kg at each day (a). Changes in mice body weight during the treatment (b). Data are presented as the average (standard deviation, )).

(a)

(b)